Clinical Trial Update: An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Participants With Previously Treated Cancer of the Colon or Rectum That Has Spread [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial of combination therapy with nivolumab and trametinib, with or without ipilimumab, in previously treated colorectal cancer; the study is comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• MEKINIST (trametinib)
• OPDIVO (nivolumab)
• Yervoy (ipilimumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Colorectal Cancer, Colorectal Tumors | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-12-03